In Brief This Week: Sequenom; DNA Electronics; ProteinSimple; Biocept; Genetic Technologies; Biomatters; Swedish Cancer Institute | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom has settled with its former CEO Harry Stylli who had made an arbitration demand with the company, Sequenom said in its Form 10-Q filed this week. Stylli made the demand in September seeking more than $1.6 million in damages. He alleged the firm fired him without cause and breached his employment agreement by failing to pay him severance benefits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.